generic drugs
Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case
March 3, 2020Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing
Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …
FDA approved over 1,000 generic drugs in 2019
February 20, 2020Research and Development, Sales and Marketing FDA, generic drugs, pharma
The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …
2019 saw the FDA approve more generic drugs than ever before
October 18, 2019Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma
Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …
China urges firms to make generic versions of 34 drugs
June 25, 2019Research and Development China, NHC, generic drugs, generics, patents, pharma
China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …
FDA expand Paragraph IV Patent Certifications List for generic drugmakers
June 19, 2019Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma
The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …
Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says
May 15, 2019Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs
Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …
FDA approves record breaking 971 generic drugs in 2018
January 10, 2019Manufacturing and Production FDA, approval, generic drugs, generics, regulation
The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …
US FDA offers plan for global regulatory harmonisation for generic drugs
October 19, 2018Medical Communications FDA, ICH, generic drugs, harmonisation, regulatory bodies
The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at …
Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO
October 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals
Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …
FDA weighs in to improve generic competition
June 27, 2017Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate
Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …
Clinton announces plan to tackle “unjustified price hikes”
September 5, 2016Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes
US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …
Latest content
FibroFind appoints Lee Borthwick as CEO
